Publications of Bozidar Novak

Filipovic, D.; Novak, B.; Xiao, J.; Yan, Y.; Bernardi, R. E.; Turck, C. W.: Chronic fluoxetine treatment in socially-isolated rats modulates the prefrontal cortex synaptoproteome. JOURNAL OF PROTEOMICS 282, 104925 (2023)

Filipovic, D.; Novak, B.; Xiao, J.; Yan, Y.; Yeoh, K.; Turck, C. W.: Chronic Fluoxetine Treatment of Socially Isolated Rats Modulates Prefrontal Cortex Proteome. NEUROSCIENCE 501, pp. 52 - 71 (2022)

Lopez, J. P.; Luecken, M. D.; Brivio, E.; Karamihalev, S.; Kos, A.; De Donno, C.; Benjamin, A.; Yang, H.; Dick, A. L. W.; Stoffel, R. et al.; Flachskamm, C.; Ressle, A.; Roeh, S.; Huettl, R. E.; Parl, A.; Eggert, C.; Novak, B.; Yan, Y.; Yeoh, K.; Lebar, M.; Hauger, B.; Harbich, D.; Schmid, B.; Di Giaimo, R.; Turck, C. W.; Schmidt, M. V.; Deussing, J. M.; Eder, M.; Dine, J.; Theis, F. J.; Chen, A.: Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2. NEURON 110 (14), pp. 2283 - 2298.e9 (2022)

Chevalier, C. M.; Krampert, L.; Schreckenbach, M.; Schubert, C. F.; Reich, J.; Novak, B.; Schmidt, M. V.; Rutten, B. P. F.; Schmidt, U.: MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans. EUROPEAN NEUROPSYCHOPHARMACOLOGY 51, pp. 20 - 32 (2021)

Herrmann, L.; Ebert, T.; Rosen, H.; Novak, B.; Philipsen, A.; Touma, C.; Schreckenbach, M.; Gassen, N. C.; Rein, T.; Schmidt, U.: Analysis of the cerebellar molecular stress response led to first evidence of a role for FKBP51 in brain FKBP52 expression in mice and humans. NEUROBIOLOGY OF STRESS 15, 100401 (2021)

Hofmann, J.; Huber, C.; Novak, B.; Schreckenbach, M.; Schubert, C. F.; Touma, C.; Rutten, B. P. F.; Schmidt, U.: Oxytocin receptor is a potential biomarker of the hyporesponsive HPA axis subtype of PTSD and might be modulated by HPA axis reactivity traits in humans and mice. PSYCHONEUROENDOCRINOLOGY 129, 105242 (2021)

Park, D. I.; Novak, B.; Yan, Y.; Kaya, M. E.; Turck, C. W.: Paroxetine binding and activation of phosphofructokinase implicates energy metabolism in antidepressant mode of action. JOURNAL OF PSYCHIATRIC RESEARCH 129, pp. 8 - 14 (2020)

Misiewicz, R. Z.; Iurato, S.; Kulesskaya, N.; Salminen, L.; Rodrigues, L.; Maccarrone, G.; Martins, J.; Czamara, D.; Laine, M. A.; Sokolowska, E. et al.; Trontti, K.; Rewerts, C.; Novak, B.; Volk, N.; Park, D. I.; Jokitalo, E.; Paulin, L.; Auvinen, P.; Voikar, V.; Chen, A.; Erhardt, A.; Turck, C. W.; Hovatta, I.: Multi-omics analysis identifies mitochondrial pathways associated with anxiety-related behavior. PLoS Genetics 15 (9), e1008358 (2019)

Naamanka, J.; Tasanko, E.; Trontti, K.; Novak, B.; Suvisaari, J.; Paunio, T.; Vaht, M.; Mattheisen, M.; Meier, S.; Metspalu, A. et al.; Daly, M.; Erhardt-Lehmann, A.; Turck, C. W.; Hartiala, J. A.; Hovatta, I.: GENOME-WIDE ANALYSIS IDENTIFIES SORCS3 AS A NOVEL SUSCEPTIBILITY LOCUS FOR PANIC DISORDER IN THE FINNGEN STUDY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 63, p. E101 - E101. (2022)